J Clin Invest 1996, 98:1954–1958 PubMedCrossRef 28 Schrager HM,

J Clin Invest 1996, 98:1954–1958.PubMedCrossRef 28. Schrager HM, Albertí S, Cywes C, Dougherty GJ, Wessels MR: Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest 1998, 101:1708–1716.PubMedCrossRef 29. Kawabata S, Kuwata H, Nakagawa I, Morimatsu S, Sano K, Hamada S: Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells. Microb Pathog 1999, Entospletinib solubility dmso 27:71–80.PubMedCrossRef 30. Darmstadt GL, Mentele L, Podbielski A, Rubens CE: Role of

group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun 2000, 68:1215–1221.PubMedCrossRef 31. CHIR98014 ic50 Stollerman GH, Dale JB: The importance of the group a streptococcus capsule in the pathogenesis of human Adriamycin solubility dmso infections: a historical perspective. Clin Infect Dis 2008, 46:1038–1045.PubMedCrossRef 32. Olsen RJ, Shelburne SA, Musser JM: Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 2009, 11:1–12.PubMedCrossRef 33. Moses AE, Wessels MR, Zalcman K, Albertí S, Natanson-Yaron S, Menes T, Hanski E: Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus . Infect Immun 1997, 65:64–71.PubMed 34. Jiang SM, Ishmael N, Hotopp JD, Puliti M, Tissi L, Kumar N, Cieslewicz MJ, Tettelin H, Wessels

MR: Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. J Bacteriol 2008, 190:1956–1965.PubMedCrossRef 35. Dalton TL, Scott JR: CovS inactivates why CovR and is required for growth

under conditions of general stress in Streptococcus pyogenes . J Bacteriol 2004, 186:3928–37.PubMedCrossRef 36. Kreikemeyer B, Nakata M, Köller T, Hildisch H, Kourakos V, Standar K, Kawabata S, Glocker MO, Podbielski A: The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region. Infect Immun 2007, 75:5698–5710.PubMedCrossRef 37. Podbielski A, Woischnik M, Leonard BA, Schmidt KH: Characterization of nra , a global negative regulator gene in group A streptococci. Mol Microbiol 1999, 31:1051–1064.PubMedCrossRef 38. Wessels MR, Bronze MS: Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci USA 1994, 91:12238–12242.PubMedCrossRef 39. Wessels MR, Goldberg JB, Moses AE, DiCesare TJ: Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun 1994, 62:433–441.PubMed 40. Bernish B, Rijn I: Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production. J Biol Chem 1999, 274:4786–93.PubMedCrossRef 41.

Comments are closed.